A Study Evaluating Daily Oral Doses of TLC-3595 in Participants With Insulin Resistance
Clinical trial NCT05665751 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05665751
- Sponsor
- OrsoBio, Inc
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-08
- Primary completion
- 2024-09-01
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.